OBIO would like to invite you to join us for an exclusive workshop focused on The Pan Canadian Pricing Alliance (pCPA). The pCPA conducts joint provincial/territorial negotiations for brand name drugs in Canada to achieve greater value for publicly funded drug programs and patients. This workshop will be valuable to all therapeutics companies.
Topics will include:
• What is pCPA and how will it affect therapeutic pricing in Canada?
• What have been the outcomes of pCPA reviews to date?
• Where is pCPA going next?